title: Hepatocellular carcinoma--Pathological complete response to oral capecitabine, megestrol and thalidomide.
authors.forename: Richard
authors.initials: R
authors.lastname: Quek
authors.forename: Soon Thye
authors.initials: ST
authors.lastname: Lim
authors.forename: Simon
authors.initials: S
authors.lastname: Ong
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069287:Capecitabine; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D018450:Disease Progression; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008535:Megestrol / Q000008:administration & dosage; D013792:Thalidomide / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D003841:Deoxycytidine; D013792:Thalidomide; D000069287:Capecitabine; D008535:Megestrol; D005472:Fluorouracil